Teva leans on Ajovy and Austedo as revenues sink
TEVA.N - | Stock Price & Latest News | Reuters
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | News Channel 3-12
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva Pharmaceuticals will pay $420 million in a federal case
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva sells Overland Park business segment - Kansas City Business Journal
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets | Business Wire
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceuticals, News And Latest Headlines - I24NEWS
